ADAMTS‐13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura
Open Access
- 5 June 2012
- journal article
- research article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 10 (8), 1556-1565
- https://doi.org/10.1111/j.1538-7836.2012.04808.x
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- ADAMTS13 activity and antigen during therapy and follow-up of patients with idiopathic thrombotic thrombocytopenic purpura: correlation with clinical outcomeHaematologica, 2011
- Different clinical severity of first episodes and recurrences of thrombotic thrombocytopenic purpuraBritish Journal of Haematology, 2010
- Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpuraHaematologica, 2010
- IgG subclasses and complement pathway in segmental and global membranous nephropathyPediatric Nephrology, 2010
- Evolution of ADAMTS13 antibodies in a fatal case of thrombotic thrombocytopenic purpuraAmerican Journal of Hematology, 2008
- The use of intermediate purity factor VIII concentrate BPL 8Y as prophylaxis and treatment in congenital thrombotic thrombocytopenic purpuraBritish Journal of Haematology, 2006
- Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpuraBlood, 2004
- Nonneutralizing IgM and IgG antibodies to von Willebrand factor–cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpuraBlood, 2003
- Thrombotic thrombocytopenic purpura: Early and late respondersAmerican Journal of Hematology, 1997
- Unusually Large Plasma Factor VIII: von Willebrand Factor Multimers in Chronic Relapsing Thrombotic Thrombocytopenic PurpuraThe New England Journal of Medicine, 1982